Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shinhan-K2 Investment Partners is a South Korean venture capital and private equity firm formed through a strategic partnership between Shinhan Capital and K2 Investment Partners. The firm specializes in growth-stage investments, with a primary focus on the life sciences, biotechnology, and healthcare sectors. Shinhan-K2 provides capital and strategic support to innovative companies developing therapeutics, medical devices, and diagnostic technologies. By leveraging the financial resources of the Shinhan Financial Group and the specialized investment expertise of K2 Investment, the firm has become a prominent backer of the South Korean biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shinhan-K2 Investment Partners.